Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ABBOTT BIOTHERAPEUTICS CORP (FACT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-09Dec-31-08Dec-31-07Dec-31-06
   8-K10-K10-K10-K
Revenues  46.118.326.751.4
            Revenue growth  152.4%-31.6%-48.1% 
Cost of goods sold  0.00.00.00.0
Gross profit  46.118.326.751.4
            Gross margin  100.0%100.0%100.0%100.0%
Selling, general and administrative   [+]38.146.345.036.6
Research and development  122.2151.3195.1200.7
EBITDA   [+] -159.2-183.3-155.9
            EBITDA margin   -871.5%-686.8%-303.2%
Depreciation   18.528.528.2
EBITA  -114.2-177.7-211.8-184.1
            EBITA margin  -247.6%-973.0%-793.6%-358.0%
Amortization of intangibles   1.61.61.8
EBIT   [+]-114.2-179.4-213.5-185.9
            EBIT margin  -247.6%-982.1%-799.8%-361.5%
Non-recurring items  29.4-19.312.20.9
Interest expense  1.71.70.60.6
Other income (expense), net  3.50.0-0.90.7
Pre-tax income  -141.7-161.7-227.2-186.6
Income taxes  0.00.10.10.1
            Tax rate  0.0%   
Net income  -141.7-161.8-227.3-186.7
            Net margin  -307.3%-886.0%-851.6%-363.1%
   
Basic EPS  ($5.90)$0.00$0.00$0.00
Diluted EPS  ($5.90)$0.00$0.00$0.00
   
Shares outstanding (basic)   [+]24.023.923.923.9
Shares outstanding (diluted)   [+]24.023.923.923.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy